OFS
OneAscent Financial Services’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,391
| Closed | -$315K | – | 201 |
|
|
2022
Q2 | $315K | Sell |
3,391
-787
| -19% | -$73.1K | 0.14% | 134 |
|
|
2022
Q1 | $490K | Buy |
4,178
+618
| +17% | +$72.5K | 0.35% | 39 |
|
|
2021
Q4 | $479K | Buy |
3,560
+109
| +3% | +$14.7K | 0.91% | 31 |
|
|
2021
Q3 | $550K | Buy |
+3,451
| New | +$550K | 0.73% | 17 |
|
|
2021
Q1 | $470K | Buy |
3,646
+929
| +34% | +$120K | 0.46% | 46 |
|
|
2020
Q4 | $453K | Sell |
2,717
-2,769
| -50% | -$462K | 0.48% | 42 |
|
|
2020
Q3 | $847K | Buy |
5,486
+1,210
| +28% | +$187K | 0.44% | 32 |
|
|
2020
Q2 | $632K | Buy |
4,276
+818
| +24% | +$121K | 0.42% | 37 |
|
|
2020
Q1 | $389K | Sell |
3,458
-1,899
| -35% | -$214K | 0.29% | 55 |
|
|
2019
Q4 | $745K | Buy |
+5,357
| New | +$745K | 0.41% | 26 |
|
|
2019
Q3 | – | Sell |
-3,891
| Closed | -$448K | – | 30 |
|
|
2019
Q2 | $448K | Buy |
+3,891
| New | +$448K | 0.31% | 59 |
|